- Home
- HSCS vs DRCT Comparison
HSCS vs DRCT Comparison
Compare HSCS & DRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSCS
- DRCT
- Stock Information
- Founded
- HSCS 2007
- DRCT 2018
- Country
- HSCS United States
- DRCT United States
- Employees
- HSCS N/A
- DRCT N/A
- Industry
- HSCS Medical Specialities
- DRCT Computer Software: Programming Data Processing
- Sector
- HSCS Health Care
- DRCT Technology
- Exchange
- HSCS Nasdaq
- DRCT Nasdaq
- Market Cap
- HSCS 8.7M
- DRCT 9.2M
- IPO Year
- HSCS 2022
- DRCT 2022
- Fundamental
- Price
- HSCS $3.33
- DRCT $0.44
- Analyst Decision
- HSCS Strong Buy
- DRCT Strong Buy
- Analyst Count
- HSCS 2
- DRCT 1
- Target Price
- HSCS $13.00
- DRCT $6.00
- AVG Volume (30 Days)
- HSCS 80.2K
- DRCT 273.3K
- Earning Date
- HSCS 09-09-2025
- DRCT 08-05-2025
- Dividend Yield
- HSCS N/A
- DRCT N/A
- EPS Growth
- HSCS N/A
- DRCT N/A
- EPS
- HSCS N/A
- DRCT N/A
- Revenue
- HSCS $4,350.00
- DRCT $36,459,000.00
- Revenue This Year
- HSCS $13,968.97
- DRCT $16.81
- Revenue Next Year
- HSCS $166.67
- DRCT $62.96
- P/E Ratio
- HSCS N/A
- DRCT N/A
- Revenue Growth
- HSCS N/A
- DRCT N/A
- 52 Week Low
- HSCS $2.36
- DRCT $0.38
- 52 Week High
- HSCS $6.47
- DRCT $6.59
- Technical
- Relative Strength Index (RSI)
- HSCS 43.80
- DRCT 44.09
- Support Level
- HSCS $3.24
- DRCT $0.43
- Resistance Level
- HSCS $3.59
- DRCT $0.49
- Average True Range (ATR)
- HSCS 0.23
- DRCT 0.03
- MACD
- HSCS -0.01
- DRCT 0.01
- Stochastic Oscillator
- HSCS 13.04
- DRCT 49.70
About HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.
About DRCT Direct Digital Holdings Inc.
Direct Digital Holdings Inc is an end-to-end, full-service programmatic advertising platform focused on providing advertising technology, data-driven campaign optimization, and other solutions to underserved and less efficient markets on both the buy-side and sell-side of the digital advertising ecosystem. The company operates two reportable segments: sell-side advertising, which includes the results of Colossus Media, and buy-side advertising, which includes the results of Orange 142 and Huddled Masses. All of the company's revenues are attributed to the United States.